FR2976180B1 - Peptides pour leur utilisation dans le traitement du cancer - Google Patents

Peptides pour leur utilisation dans le traitement du cancer

Info

Publication number
FR2976180B1
FR2976180B1 FR1155090A FR1155090A FR2976180B1 FR 2976180 B1 FR2976180 B1 FR 2976180B1 FR 1155090 A FR1155090 A FR 1155090A FR 1155090 A FR1155090 A FR 1155090A FR 2976180 B1 FR2976180 B1 FR 2976180B1
Authority
FR
France
Prior art keywords
peptides
cancer
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1155090A
Other languages
English (en)
Other versions
FR2976180A1 (fr
Inventor
Jean-Marc Berjeaud
Clemence Loiseau
Martine Tamisier
Adrienne Marchand
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Universite de Poitiers
Original Assignee
Centre National de la Recherche Scientifique CNRS
Universite de Poitiers
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, Universite de Poitiers filed Critical Centre National de la Recherche Scientifique CNRS
Priority to FR1155090A priority Critical patent/FR2976180B1/fr
Priority to PCT/IB2012/052896 priority patent/WO2012168908A1/fr
Publication of FR2976180A1 publication Critical patent/FR2976180A1/fr
Application granted granted Critical
Publication of FR2976180B1 publication Critical patent/FR2976180B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
FR1155090A 2011-06-10 2011-06-10 Peptides pour leur utilisation dans le traitement du cancer Expired - Fee Related FR2976180B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR1155090A FR2976180B1 (fr) 2011-06-10 2011-06-10 Peptides pour leur utilisation dans le traitement du cancer
PCT/IB2012/052896 WO2012168908A1 (fr) 2011-06-10 2012-06-08 Peptides pour leur utilisation dans le traitement du cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1155090A FR2976180B1 (fr) 2011-06-10 2011-06-10 Peptides pour leur utilisation dans le traitement du cancer

Publications (2)

Publication Number Publication Date
FR2976180A1 FR2976180A1 (fr) 2012-12-14
FR2976180B1 true FR2976180B1 (fr) 2013-07-05

Family

ID=46354444

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1155090A Expired - Fee Related FR2976180B1 (fr) 2011-06-10 2011-06-10 Peptides pour leur utilisation dans le traitement du cancer

Country Status (2)

Country Link
FR (1) FR2976180B1 (fr)
WO (1) WO2012168908A1 (fr)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2894969B1 (fr) * 2005-12-20 2008-02-22 Centre Nat Rech Scient Peptides actifs contre les bacteries du genre legionella

Also Published As

Publication number Publication date
FR2976180A1 (fr) 2012-12-14
WO2012168908A1 (fr) 2012-12-13

Similar Documents

Publication Publication Date Title
FR22C1002I2 (fr) Inhibiteurs ibat pour le traitement de maladies du foie
HK1222552A1 (zh) 索布替羅用於治療髓鞘形成疾病
DK2919796T3 (da) Brug af akkermansia til behandling af stofskiftesygdomme
CO7020866A2 (es) Péptidos terapéuticos
LU91805B1 (fr) Compositions inhibitrices de virus pour une utilisation therapeutique in vivo
GB201115711D0 (en) Phyto-cannabinoids for use in the treatment of cancer
DK3415525T3 (da) Amfipatisk peptid
DK2863942T3 (da) Peptidkonjugerede partikler
HK1210061A1 (en) Self-supporting interface dressing
DK2903629T3 (da) Antistofkonjugat til anvendelse ved behandling af inflammatorisk tarmsygdom
HK1246694A1 (zh) α胸腺肽用於膿毒症治療的用途
FR2990945B1 (fr) Nouveaux analogues de strigolactone et leur utilisation pour le traitement des plantes
FR3000491B1 (fr) Composes utilisables dans le traitement des infections mycobacteriennes
PT2872176T (pt) Carboranilporpirinas para utilização no tratamento de cancro
FR2962586B1 (fr) Panneau pour le traitement acoustique
IL239078A0 (en) Protein for use in the treatment of eye diseases
PL2943215T3 (pl) Peptydy pochodzące z laktoferycyny do zastosowania w leczeniu nowotworu
FR3000399B1 (fr) Utilisation topique du laropiprant pour le traitement de la rosacee
FR2987267B1 (fr) Application du modafinil dans le traitement de substitution des cacainomanes
FR2976806B1 (fr) Composition topique filmogene et son utilisation pour le traitement des mycoses
FR2976180B1 (fr) Peptides pour leur utilisation dans le traitement du cancer
FR2996847B1 (fr) Composes 3,4-bis(catechol)pyrrole-n-substitues, leur preparation et utilisation dans le traitement du cancer
FR2976492B1 (fr) Electrode combinee pour le traitement de l'hyperhidrose axillaire
FR2992863B1 (fr) Composition pharmaceutique pour le traitement du cancer
FR2976493B1 (fr) Electrode combinee pour le traitement de l'hyperhidrose

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20150227